Repare Therapeutics Stock Analysis

Repare Stock Analysis Notes

About 84.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Repare Therapeutics recorded a loss per share of 1.99. The entity had not issued any dividends in recent years. Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company was incorporated in 2016 and is headquartered in Montreal, Canada. Repare Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 163 people. To find out more about Repare Therapeutics contact Lloyd Segal at 857 412 7018 or learn more at https://www.reparerx.com.

Repare Therapeutics Investment Alerts

Repare Therapeutics Upcoming and Recent Events

Repare Largest EPS Surprises

View All Earnings Estimates

Repare Therapeutics Environmental, Social, and Governance (ESG) Scores

Repare Stock Institutional Investors

Note, although Repare Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Repare Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 133.91 M.

Repare Profitablity

The company has Profit Margin (PM) of (1.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.39.

Management Efficiency

Repare Therapeutics has return on total asset (ROA) of (0.2339) % which means that it has lost $0.2339 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4117) %, meaning that it created substantial loss on money invested by shareholders. Repare Therapeutics' management efficiency ratios could be used to measure how well Repare Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.39 in 2024. Return On Capital Employed is likely to drop to -0.57 in 2024. At this time, Repare Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 2.8 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 173 M in 2024.

Technical Drivers

As of the 28th of November, Repare Therapeutics holds the Semi Deviation of 3.5, coefficient of variation of 4826.32, and Risk Adjusted Performance of 0.0242. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repare Therapeutics, as well as the relationship between them.

Repare Therapeutics Price Movement Analysis

Repare Therapeutics Insider Trading Activities

Repare Therapeutics Outstanding Bonds

Repare Therapeutics Predictive Daily Indicators

Repare Therapeutics Corporate Filings

Repare Therapeutics Forecast Models

Repare Therapeutics' time-series forecasting models are one of many Repare Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repare Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Repare Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repare shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repare Therapeutics. By using and applying Repare Stock analysis, traders can create a robust methodology for identifying Repare entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repare analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Repare analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Repare Therapeutics stock analysis indicators help investors evaluate how Repare Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Repare Therapeutics shares will generate the highest return on investment. By understating and applying Repare Therapeutics stock analysis, traders can identify Repare Therapeutics position entry and exit signals to maximize returns.

When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.